As a leading CRO/CDMO for over 13 years, Applied StemCell offers comprehensive research- and GMP-grade iPSC and gene editing solutions for the development of gene and cell products. We established a TARGATT master iPSC platform for safe, efficient, site-specific, and large cargo (up to 20kb) transgene insertion at over 40% insertion rate without selection. This platform is tested for the development of allogeneic iPSC-CAR-NK products. ASC is on a mission to assist in the development and manufacturing of novel therapeutics, and we seek to form partnerships focused on iPSC-based therapies.
Cellino is an autonomous, closed loop cell therapy manufacturing company. The company is on a mission to democratize stem cell-based therapies for all eligible patients. Cellino’s next-generation process combines label-free imaging, high-speed laser editing, and artificial intelligence (AI) to automate cell reprogramming, expansion, and differentiation in a closed cassette format. Cellino’s approach enables the parallel processing of thousands of patient samples in a single facility, which is vital for scalable manufacturing
PBS Biotech, Inc. offers unique single-use bioreactors and contract process development services for the global cell therapy market. Our family of Vertical-Wheel® bioreactors provides optimal and scalable hydrodynamic conditions for human cells such as induced pluripotent stem cells grown as aggregates or mesenchymal stem cells grown on the surface of microcarriers. Our Bioprocess R&D team possesses unparalleled knowledge regarding cell culture process development for a variety of cell types and applications. PBS Biotech is committed to providing scalable solutions for all stages of cell therapy manufacturing, from R&D to clinical studies and ultimately commercial production.
Lonza is the preferred global partner to the pharmaceutical, biotech and nutrition markets. We work to prevent illness and enable a healthier world by supporting our customers to deliver new and innovative medicines that help treat a wide range of diseases. We achieve this by combining technological insight with world-class manufacturing, scientific expertise and process excellence. These enable our customers to commercialize their discoveries and innovations in the healthcare sector.
MAGic BioProcessing provide ULTIMATE products and methodology for isolation and purification of mAb’s and cell. The company develops and produces proprietary and fully scaleable magnetic-based bioprocessing products and methodologies for the isolation and purification of biologics from μl to thousands of liters of cell culture material.